• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非白念珠菌属念珠菌引起的成年住院患者念珠菌血症相对流行率的变化:系统评价、荟萃分析和荟萃回归。

Changes in the relative prevalence of candidaemia due to non-albicans Candida species in adult in-patients: A systematic review, meta-analysis and meta-regression.

机构信息

Clinica Malattie Infettive, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy.

Department of Health Sciences, University of Genoa, Genoa, Italy.

出版信息

Mycoses. 2020 Apr;63(4):334-342. doi: 10.1111/myc.13054.

DOI:10.1111/myc.13054
PMID:31997414
Abstract

BACKGROUND

Candidaemia remains associated with high mortality and increased costs worldwide.

OBJECTIVE

To assess the changes over time in the relative prevalence of non-albicans candidaemia (NAC).

METHODS

A systematic review, meta-analysis and meta-regression were performed. Observational studies investigating the epidemiology of consecutive, non-selected, candidaemia episodes were included. Two separated analyses were conducted: (a) whole hospital analysis and (b) intensive care unit (ICU) analysis.

RESULTS

Starting from an initial total of 7726 records, 220 studies fulfilled inclusion criteria. The pooled prevalence of NAC in whole hospital analysis was 49.5% (95% confidence intervals [CI] 48.0-51.1, I 93.1%), while the pooled prevalence in ICU analysis was 50.6% (95% CI 46.6-54.6; I 86.7%). In meta-regression, a progressive increase in NAC prevalence was observed in whole hospital analysis, although it explained only a small portion of between-study variance (estimated yearly prevalence change +0.3%, 95% CI from +0.1% to +0.5%, P = .003; adjusted R 3.42%) and was observed only in some continents in subgroup analyses. No relevant changes over time were observed in NAC prevalence for ICU studies.

CONCLUSIONS

We registered an increasing trend in the relative prevalence of NAC, which, nonetheless, seems to be limited to some continents and to contribute only minimally to explain the observed differences in NAC prevalence across studies.

摘要

背景

念珠菌血症仍然与全球范围内的高死亡率和增加的成本相关。

目的

评估非白念珠菌性念珠菌血症(NAC)相对流行率随时间的变化。

方法

进行了系统评价、荟萃分析和荟萃回归。纳入了研究连续、非选择性念珠菌血症发作的流行病学的观察性研究。进行了两次独立的分析:(a)全院分析和(b)重症监护病房(ICU)分析。

结果

从最初的 7726 条记录中,有 220 项研究符合纳入标准。全院分析中 NAC 的总流行率为 49.5%(95%置信区间[CI]48.0-51.1,I 93.1%),而 ICU 分析中的流行率为 50.6%(95%CI46.6-54.6;I 86.7%)。在荟萃回归中,尽管仅解释了研究间差异的一小部分(估计每年流行率变化+0.3%,95%CI 从+0.1%到+0.5%,P=.003;调整后的 R 3.42%),但在全院分析中观察到 NAC 流行率呈渐进性增加,且仅在一些大陆的亚组分析中观察到。ICU 研究中 NAC 流行率未观察到随时间的相关变化。

结论

我们记录到 NAC 相对流行率呈上升趋势,但这种趋势似乎仅限于某些大陆,并且仅对解释研究中 NAC 流行率的差异贡献极小。

相似文献

1
Changes in the relative prevalence of candidaemia due to non-albicans Candida species in adult in-patients: A systematic review, meta-analysis and meta-regression.非白念珠菌属念珠菌引起的成年住院患者念珠菌血症相对流行率的变化:系统评价、荟萃分析和荟萃回归。
Mycoses. 2020 Apr;63(4):334-342. doi: 10.1111/myc.13054.
2
Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis.欧洲念珠菌血症的发病率和死亡率:一项流行病学荟萃分析。
Clin Microbiol Infect. 2019 Oct;25(10):1200-1212. doi: 10.1016/j.cmi.2019.04.024. Epub 2019 Apr 27.
3
Risk of invasive candidiasis with prolonged duration of ICU stay: a systematic review and meta-analysis.ICU 住院时间延长与侵袭性念珠菌病风险:系统评价和荟萃分析。
BMJ Open. 2020 Jul 12;10(7):e036452. doi: 10.1136/bmjopen-2019-036452.
4
Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010.一所三级护理大学医院念珠菌血症的流行病学:2001年至2010年期间381例念珠菌血症发作的10年经验。
Mycoses. 2015 Aug;58(8):498-505. doi: 10.1111/myc.12349. Epub 2015 Jul 7.
5
ICU-acquired candidaemia in France: Epidemiology and temporal trends, 2004-2013 - A study from the REA-RAISIN network.法国 ICU 获得性念珠菌血症:流行病学和时间趋势,2004-2013 年——来自 REA-RAISIN 网络的研究。
J Infect. 2017 Jul;75(1):59-67. doi: 10.1016/j.jinf.2017.03.011. Epub 2017 Mar 31.
6
Epidemiology, species distribution, clinical characteristics and mortality of candidaemia in a tertiary care university hospital in Turkey, 2007-2014.2007 - 2014年土耳其一所三级护理大学医院念珠菌血症的流行病学、菌种分布、临床特征及死亡率
Mycoses. 2017 Jul;60(7):433-439. doi: 10.1111/myc.12618. Epub 2017 Mar 24.
7
Epidemiology, risk factors and outcomes of non- candidaemia in adult patients in Northeast China.中国东北地区成人非念珠菌血症的流行病学、危险因素和结局。
Epidemiol Infect. 2019 Sep 25;147:e277. doi: 10.1017/S0950268819001638.
8
Microbial epidemiology of candidaemia in neonatal and paediatric intensive care units at the Children's Medical Center, Tehran.德黑兰儿医中心新生儿与小儿加护病房念珠菌血症的微生物流行病学。
Mycoses. 2018 Jan;61(1):22-29. doi: 10.1111/myc.12698. Epub 2017 Sep 22.
9
Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study.亚洲念珠菌血症的发病率和菌种分布:一项基于实验室的监测研究。
Clin Microbiol Infect. 2015 Oct;21(10):946-53. doi: 10.1016/j.cmi.2015.06.010. Epub 2015 Jun 20.
10
Candida auris candidaemia in an intensive care unit - Prospective observational study to evaluate epidemiology, risk factors, and outcome.耳念珠菌菌血症在重症监护病房的流行情况—一项评估流行病学、风险因素和预后的前瞻性观察研究。
J Crit Care. 2020 Jun;57:42-48. doi: 10.1016/j.jcrc.2020.01.004. Epub 2020 Jan 9.

引用本文的文献

1
Invasive Candidiasis in the Intensive Care Unit: Where Are We Now?重症监护病房中的侵袭性念珠菌病:我们目前的状况如何?
J Fungi (Basel). 2025 Mar 27;11(4):258. doi: 10.3390/jof11040258.
2
Species-Specific Sensitivity and Levels of Beta-D-Glucan for the Diagnosis of Candidemia-A Systematic Review and Meta-Analysis.用于念珠菌血症诊断的β-D-葡聚糖的种属特异性敏感性和水平——一项系统评价和荟萃分析
J Fungi (Basel). 2025 Feb 15;11(2):149. doi: 10.3390/jof11020149.
3
Humanized Candida and NanoBiT Assays Expedite Discovery of Bdf1 Bromodomain Inhibitors With Antifungal Potential.
人源化念珠菌和纳米BiT检测法加速发现具有抗真菌潜力的Bdf1溴结构域抑制剂。
Adv Sci (Weinh). 2025 Mar;12(10):e2404260. doi: 10.1002/advs.202404260. Epub 2025 Jan 16.
4
A Narrative Review of Invasive Candidiasis in the Intensive Care Unit.重症监护病房侵袭性念珠菌病的叙述性综述
Ther Adv Pulm Crit Care Med. 2024 Dec 12;19:29768675241304684. doi: 10.1177/29768675241304684. eCollection 2024 Jan-Dec.
5
Prevalence, Species Distribution and Resistance of Candidemia in Pediatric and Adult Patients in a Northeast Italy University Hospital.意大利东北部一家大学医院儿科和成人患者念珠菌血症的患病率、菌种分布及耐药性
J Fungi (Basel). 2024 Oct 10;10(10):707. doi: 10.3390/jof10100707.
6
Comparative analysis of enzymatic profiles and biofilm formation in clinical and environmental Candida kefyr isolates.临床和环境来源的近平滑假丝酵母分离株的酶谱和生物膜形成的比较分析。
Environ Microbiol Rep. 2024 Jun;16(3):e13282. doi: 10.1111/1758-2229.13282.
7
Evaluation of Antifungal Selective Toxicity Using and Human Knock-In Strains.使用人类基因敲入菌株评估抗真菌选择性毒性
J Fungi (Basel). 2023 Oct 20;9(10):1035. doi: 10.3390/jof9101035.
8
Antimicrobial and antioxidant potential of the silver nanoparticles synthesized using aqueous extracts of coconut meat (Cocos nucifera L).采用椰肉(Cocos nucifera L.)水提物合成的银纳米粒子的抗菌和抗氧化潜力。
Sci Rep. 2023 Sep 27;13(1):16270. doi: 10.1038/s41598-023-43384-4.
9
Challenges in the diagnosis and treatment of candidemia due to multidrug-resistant .耐多药念珠菌血症的诊断与治疗挑战
Front Fungal Biol. 2023 Feb 2;4:1061150. doi: 10.3389/ffunb.2023.1061150. eCollection 2023.
10
Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial.新型抗真菌药物福沙莫尼酯治疗念珠菌血症的临床安全性和疗效:一项 2 期试验结果。
J Antimicrob Chemother. 2023 Oct 3;78(10):2471-2480. doi: 10.1093/jac/dkad256.